Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Vaqta Market Size And Revenue Outlook Through 2030
Historically, the observed growth was propelled by several key factors: the broadening of routine vaccination programs, a surge in hepatitis A outbreaks, heightened international travel, state-sponsored vaccination drives, and enhanced vaccine production quality.
Anticipated growth during the forecast period is primarily driven by a stronger commitment to achieving universal vaccination, increased financial contributions to public health infrastructure, the expansion of immunization programs targeting adults and the elderly, an escalating need for multi-component vaccine strategies, and greater uptake in emerging economies.
Key developments expected during the forecast period encompass a heightened focus on proactive vaccination initiatives, the growing acceptance of immunizations for travel purposes, an intensifying effort to improve adult immunization rates, the broadening of temperature-controlled vaccine distribution networks, and more impactful public health education campaigns.
Get A Free Sample Report With In-Depth Market Insights:
Vaqta Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of hepatitis A is anticipated to boost the expansion of the vaqta market moving forward. This liver-targeting viral infection, known as hepatitis A, is exceptionally transmissible and originates from the hepatitis A virus (HAV). Various elements contribute to the escalating number of hepatitis A cases, such as inadequate sanitation and hygiene practices, community-level outbreaks, groups lacking vaccination, food-related infections, and environmental influences. The vaqta vaccine plays a role in countering the surge in hepatitis A infections by halting the virus’s transmission, particularly within vulnerable regions. For instance, in April 2025, according to the Health Security Agency UK-based government agency, in the UK, hepatitis A virus infections typically number around 400 cases per year, but cases have risen, exceeding 800 in 2024. Consequently, the increased occurrence of hepatitis A is propelling the expansion of the vaqta market.
Vaqta Market Segment Landscape: Which Areas Lead Development?
The vaqta market covered in this report is segmented –
1) By Indication: Hepatitis A Vaccination, Travel Vaccination, Routine Vaccination
2) By Age Group: Pediatrics, Adults, Elderly
3) By Distribution Channel: Hospital And Clinics, Retail Pharmacies, Specialty Pharmacies
4) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care
Vaqta Market Industry Leaders And Competitive Landscape
Major companies operating in the vaqta market are Merck & Co. Inc.
View The Full Vaqta Market Report:
Vaqta Market Geographic Distribution And Regional Opportunities
North America was the largest region in the vaqta market in 2025. The regions covered in the vaqta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
